Last $12.77 USD
Change Today +0.235 / 1.88%
Volume 559.7K
NKTR On Other Exchanges
As of 12:10 PM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rinko Ghosh

Former Chief Business Officer and Senior Vice President, Nektar Therapeutics
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. Rinko Ghosh served as the Chief Business Officer and Senior Vice President at Nektar Therapeutics from March 2010 to March 15, 2014. Mr. Ghosh served as Senior Vice President of Business Development and Alliance Management at Nektar Therapeutics from March 2008 to February 2010, Vice President of Business Development from August 2006 to February 2008, Senior Director of Business Development from July 2005 to July 2006. Prior to that, he worked in a variety of corporate ...

Read Full Background

Corporate Headquarters*

455 Mission Bay Boulevard South
San Francisco, California 94158

United States

Phone: 415-482-5300
Fax: 415-339-5300

Board Members Memberships*

There is no Board Members Memberships data available.


Vanderbilt University
University of Pennsylvania - The Wharton School
Indian Institute of Technology, Bombay

Other Affiliations*

Annual Compensation*

Total Annual Compensation$453,994

Stock Options*

All Other Compensation$7,436
Exercisable Options671,147
Exercisable Options Value$1,645,766
Unexercisable Options173,753
Unexercisable Options Value$445,434
Total Value of Options$2,091,200
Total Number of Options844,900

Total Compensation*

Total Annual Cash Compensation$666,225
Total Short Term Compensation$453,994
Other Long Term Compensation$7,436
Total Calculated Compensation$1,125,595
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NKTR:US $12.77 USD +0.235


Michael W. Aguiar Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Senior Vice President of Finance, Treasurer and Director
Theravance Inc.
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEKTAR THERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at